Institutional Ownership
Nw Biotherapeutics
CUSIP 66737P600COMNWBOQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Kelleher Financial Advisors | 200.0K | $41.3K |
| 2 | Vsm Wealth Advisory, LLC | 80.6K | $16.6K |
| 3 | Ethos Financial Group, LLC | 39.1K | $8.1K |
| 4 | Williams Jones Wealth Management, LLC. | 25.0K | $5.2K |
| 5 | Mcilrath & Eck, LLC | 600 | $124 |
| 6 | Opus Capital Group, LLC | 60.1K | $12 |
| 7 | Hantz Financial Services, Inc. | 250 | $0 |
| 8 | Coston, Mcisaac & Partners | 1.0K | $0 |